Citicoline for newborn brain injury from lack of oxygen
Treatments studied
Part of Brain & nervous system, Heart & circulation clinical trials.
This study tests a medicine called citicoline to see if it can help babies who had a lack of oxygen around birth (which can lead to brain injury). The goal is to reduce brain damage and improve recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Newborn baby, born at 35 weeks or later
- Had a low Apgar score (less than 8/10) at 5 minutes after birth
- Shows signs of oxygen shortage during birth (perinatal asphyxia) and is seen within the first day of life
- Has not already received therapeutic hypothermia (cooling treatment)
- No birth defects, developmental issues, or chromosomal conditions
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether a medicine called citicoline can protect the brain in newborns who had low oxygen (hypoxia). It may help reduce brain injury in babies, but it does not include babies with a specific severe brain condition.
This trial tests if giving caffeine to newborns who had low oxygen at birth can help protect their brains. It compares caffeine plus standard care to placebo plus standard care for moderate to severe hypoxic ischemic encephalopathy (HIE).
This Phase 3 study tests whether citicoline can act as a protective treatment for the brain in babies born early and needing breathing support. It may help reduce risks tied to prematurity and breathing complications by supporting the brain’s health.
This early-phase study tests whether using a baby’s own cord blood stem cells is safe and feasible for newborns with brain injury from lack of oxygen around birth. It may help researchers find new ways to treat hypoxic-ischemic encephalopathy (brain injury due to oxygen deprivation) in addition to standard care like cooling.
This trial studies whether cooling a newborn's body after a difficult birth helps prevent brain damage. Researchers will track babies treated with this cooling therapy and use brain imaging to see how well it works.
This trial tests whether giving both magnesium sulfate and melatonin to newborns with brain injury from lack of oxygen works better than magnesium sulfate alone. The goal is to see if the combination improves recovery and reduces long-term disability.
Hear when a new Hypoxic Ischaemic Encephalopathy (HIE) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.